Valuation: Abbott Laboratories

Market Cap 172B 154B 144B 130B 246B 16,504B 248B 1,729B 677B 8,502B 647B 633B 27,335B P/E 2026 *
29.2x
P/E 2027 * 22.6x
Enterprise Value 196B 176B 164B 149B 280B 18,796B 282B 1,970B 771B 9,683B 737B 721B 31,132B EV / Sales 2026 *
3.91x
EV / Sales 2027 * 3.54x
Free-Float
86.16%
Yield 2026 *
2.58%
Yield 2027 * 2.75%
1 day+2.23%
1 week+1.72%
Current month+3.03%
1 month-0.13%
3 months+8.40%
6 months+1.52%
Current year-18.73%
1 week 97.2
Extreme 97.2
102.06
1 month 95.06
Extreme 95.06
104.54
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
133.34
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap. Importance
9/30/26 Free

Director

333 0.0000%
9/30/26 Free

Director

318 0.0000%
9/30/26 Free

Director

381 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.23%+1.72%-23.20%+12.89% 172B
+3.90%+4.50%-3.69%+28.95% 113B
+1.90%-0.92%-22.49%+11.33% 106B
+0.27%+1.56%-46.32%-11.83% 75.31B
+0.37%+3.22%+2.22%+73.30% 61.8B
+0.12%+2.27%+15.06%+60.71% 52.93B
+2.80%+4.55%+1.25%-26.52% 50.05B
+1.15%-0.59%-14.97%+22.33% 40.81B
-1.38%-0.11% - - 31.81B
+2.15%-1.13%+31.94%+13.82% 31.74B
Average +0.89%+2.04%-6.69%+20.55% 73.64B
Weighted average by Cap. +1.04%+2.17%-12.63%+19.27%

Financials

2026 *2027 *
Net sales 50.2B 44.99B 41.89B 38.01B 71.69B 4,807B 72.14B 504B 197B 2,476B 189B 184B 7,962B 54.53B 48.87B 45.5B 41.29B 77.87B 5,222B 78.36B 547B 214B 2,690B 205B 200B 8,649B
Net income 6.21B 5.57B 5.18B 4.7B 8.87B 595B 8.93B 62.33B 24.39B 306B 23.33B 22.82B 985B 7.89B 7.07B 6.59B 5.98B 11.27B 756B 11.34B 79.21B 31B 389B 29.64B 28.99B 1,252B
Net Debt 23.94B 21.45B 19.97B 18.12B 34.19B 2,292B 34.4B 240B 94B 1,181B 89.9B 87.92B 3,797B 20.96B 18.78B 17.49B 15.87B 29.93B 2,007B 30.11B 210B 82.29B 1,034B 78.7B 76.97B 3,324B
Projected Income Statement - Annual - Abbott Laboratories
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-10-12 US$101.82 +2.23% 6,831,195
26-10-09 US$99.60 +1.13% 6,962,016
26-10-08 US$98.49 -0.24% 13,909,636
26-10-07 US$98.73 +0.58% 9,392,437
26-10-06 US$98.16 -1.94% 10,577,127
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Abbott Laboratories
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
99.60USD
Average target price
120.72USD
Spread / Average Target
+21.20%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Abbott Laboratories